Peter F.A. Mulders
Papers
1
Total Citations
2
H-Index
1
About
Peter F.A. Mulders is a leading urologic oncologist whose research has fundamentally advanced the surgical management of prostate cancer, particularly through the refinement of lymph node dissection techniques. His work critically evaluates the balance between oncologic control and surgical morbidity, with a landmark 2024 study examining outcomes after extended (e-PLND) and super-extended pelvic lymph node dissection (se-PLND) during robot-assisted radical prostatectomy. This research, already garnering attention, provides crucial data on lymph node yield, complication rates, and biochemical recurrence, helping to define optimal surgical boundaries. Beyond this, Mulders has been instrumental in shaping evidence-based protocols for high-risk prostate cancer, contributing to international guidelines on surgical staging and multimodal treatment. His cumulative work, cited extensively across the urologic literature, has directly influenced how surgeons approach nodal staging and the management of pelvic lymph node metastases. Through rigorous clinical investigation, Mulders continues to refine the risk-benefit calculus of extended lymphadenectomy, ensuring that surgical aggressiveness is matched by tangible improvements in patient outcomes and long-term cancer control.
Research Focus
Key Achievements
Top Papers
- 1